330EGP
- Active ingredient
- solifenacin succinate+mirabegron
- Strength
- 5/50mg
- Form
- tablet
- Manufacturer
- utopia pharmaceuticals company
- Route
- oral.solid
Uses
Used for treatment of overactive bladder with urgency, frequency, and urge urinary incontinence.
Do not use if
Urinary retention, gastric retention, uncontrolled severe hypertension, or hypersensitivity to any ingredient.
Side effects
Dry mouth, constipation, urinary tract infection, headache, and hypertension may occur.
Warnings
Use cautiously in patients with urinary retention risk or elevated blood pressure.
How it works
Combines beta-3 adrenergic receptor stimulation with muscarinic receptor blockade to improve bladder storage function.
Storage
Store at room temperature.